MaxCyte Inc (NAS:MXCT)
$ 3.86 0.1 (2.66%) Market Cap: 392.05 Mil Enterprise Value: 253.21 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 75/100

Q4 2022 MaxCyte Inc Earnings Call Transcript

Mar 15, 2023 / 08:30PM GMT
Release Date Price: $4.2 (+2.69%)
Operator

Good day, and thank you for standing by, and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sean Menarguez of Investor Relations. You may begin.

Sean Menarguez
MaxCyte, Inc. - Director of IR

Thank you, Justin. Good afternoon, everyone. My name is Sean Menarguez, and I'm the Head of Investor Relations here at MaxCyte. Thank you all for participating in today's conference call. On the call from MaxCyte, we have Douglas Doerfler, President and Chief Executive Officer and Ron Holtz, Interim Chief Financial Officer.

Earlier today, MaxCyte released financial results for the fourth quarter and full year ended December 31, 2022. A copy of the press release is available on the company's website. Before we begin, I need to read the following statements. Statements or comments made during this call may be forward-looking statements within the meaning of federal securities laws. Any statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot